
As a The Lord of the Rings and Radiopharmaceutical Therapy enthusiast (well, nerd...) that must be my favorite article title of the year...
✓🇮🇸Medical Oncologist/Educator, NET/GI/CUP enthusiast. Husband/dadx4 (bad dad jokes). Cyclist. Avant gardener. Professor of Oncology, Mayo Clinic. Tweets mine.

As a The Lord of the Rings and Radiopharmaceutical Therapy enthusiast (well, nerd...) that must be my favorite article title of the year...

As is tradition, smoke appears from the MI6 building to mark the selection of a new James Bond

There are a lot of pearls in this excellent paper and I would like to share one of them... We often see patients referred for "neuroendocrine neoplasms" where there is only one surface marker positive, often weakly positive, or more than one patchy/weak positive stain and morphology incompatible with a NEN. Many adenocarcinomas may stain positive for NE markers but still be adenocarcinomas and not NENs and therefore no surprise if they do not behave like NENs...

OK, last NEN article post of the night (thanks, Delta, for excellent in-air wifi and for keeping me hypercaffeinated). This is a really cool paper, an @ENETS_ORG consensus paper led by @JHernando3, an expert panel, on unresolved clinical scenarios and emerging approaches with somatostatin analogues. Yes, I read it already! It is great, clinically helpful, hits many of the classic SSA controversies, and if you see patients with NETs, you should read it too... onlinelibrary.wiley.com/doi/…

Are you like me, feeling intimidated by and unsure about the management of patient with mixed neuroendocrine/non-neuroendocrine neoplasms (MiNENs) of gastroenteropancreatic origin? If so, this is a review article you will want to read. Excellent @ENETS_ORG position statement, led by @FRANCES88189587 and a panel of folks who know their stuff. Check it out! onlinelibrary.wiley.com/doi/…

Were you looking for an excellent review on neuroendocrine neoplasm pathology focusing on the challenges of biopsy diagnoses written by true experts in the field? Worry not, I got you... link.springer.com/article/10…

Matthew R. Callstrom, M.D., Ph.D., has been elected by the Mayo Clinic Board of Trustees to succeed Gianrico Farrugia, M.D., as president and CEO, effective Jan. 1, 2027. Read the full announcement: mayocl.in/4zMJdVZ

Do you want to know more about the management of hepato-pancreato-biliary (including neuroendocrine) malignancies? Maybe learn from experts like @AGangiMD on the surgical management of pancreatic NETs but she provided an excellent overview from which the following slides were lifted...? Then mark your 2027 calendar and join us for the 2027 Hepato-Pancreatico-Biliary Cancer Symposium on Nov 5-6, 2027. Ideal content for anyone taking care of such patients, especially trainees in surgery and oncology. Cutting edge and practical. ce.mayo.edu/gastroenterology… @MayoCancerCare @GIcancerDoc @MiteshBorad

Congratulations to Mayo Clinic’s next president and CEO, Dr. Matthew Callstrom. Mayo has put Minnesota on the map for world-class health care, and I can’t wait to build on Minnesota’s legacy of medical innovation. postbulletin.com/health/mayo…

Back in Las Vegas within a week of NANETS. This time with half a day to spare… Did you know that mountain biking in Las Vegas is great? Check out the Trek store and rental in Blue Diamond. Fantastic service and nice folks.

Happy #NETCancerDay! 💜 Grateful for the clinicians, researchers, and partners who made #NANETS2026 in Las Vegas such a success. Together, we’re advancing NET care. See you in Scottsdale, Oct 28–30, 2027! #NeuroendocrineTumors #NETCancerDay

The NANETS highlights for me are always the trainees presenting their work at the poster board and sometimes the podium. Excellent work by a future colleague, @PomerantzLauren on thymic and bronchial NETs in patients with MEN1. It truly is a privilege to work with such talented colleagues. The future is bright! @PatrickMcGarrah @OmairShariq @sonbol_bassam @KLeventakos

Post-NANETS gravel ride in Minnesota. Delicious weather and still some corn unharvested. Not many days like this left in 2026, at least not in Minnesota…

Agree 100%.

This was incredibly well deserved, @UGrewalMD and also utterly unsurprising… 😉 Congratulations!!!🎉🎊 I can rest assured that the future of NEN research is in good hands…

I use the Rising Star definition sparingly but today, it is so appropriate. Amazing accomplishments, not just in NENs but in GI oncology in general. Congratulations, @sonbol_bassam !!!